Literature DB >> 10417163

Thymic independence of adaptive immunity to the intracellular pathogen Shigella flexneri serotype 2a.

S S Way1, A C Borczuk, M B Goldberg.   

Abstract

Shigella flexneri is a facultative intracellular pathogen. While immunity to several intracellular pathogens is mediated by T lymphocytes, it is unknown whether cellular immune responses are important to adaptive immunity to S. flexneri. We show that vaccination with S. flexneri serotype 2a confers protection to mice that lack T lymphocytes or gamma interferon (IFN-gamma), specific depletion of T lymphocytes does not alter the protection, and adoptive transfer of splenocytes from vaccinated mice does not confer protection to naive mice. In contrast, vaccination conferred no protection to mice that lack B lymphocytes and adoptive transfer of immune sera conferred partial protection to naive mice. These data demonstrate that in the mouse bronchopulmonary model, adaptive immunity to S. flexneri 2a is an antibody-mediated, B-lymphocyte-dependent process and can be generated in the absence of T lymphocytes or IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417163      PMCID: PMC96681     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  69 in total

1.  Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.

Authors:  W P Reed
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity.

Authors:  M E Mielke; S Ehlers; H Hahn
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

3.  A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes.

Authors:  M A Miller; M J Skeen; H K Ziegler
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

Review 4.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra- and intercellular spread through interaction with F-actin.

Authors:  M L Bernardini; J Mounier; H d'Hauteville; M Coquis-Rondon; P J Sansonetti
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence.

Authors:  S S Way; S Sallustio; R S Magliozzo; M B Goldberg
Journal:  J Bacteriol       Date:  1999-02       Impact factor: 3.490

7.  Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.

Authors:  P Mombaerts; A R Clarke; M A Rudnicki; J Iacomini; S Itohara; J J Lafaille; L Wang; Y Ichikawa; R Jaenisch; M L Hooper
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

8.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

Authors:  D K Dalton; S Pitts-Meek; S Keshav; I S Figari; A Bradley; T A Stewart
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

10.  Cloned Listeria monocytogenes specific non-MHC-restricted Lyt-2+ T cells with cytolytic and protective activity.

Authors:  S H Kaufmann; H R Rodewald; E Hug; G De Libero
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

View more
  11 in total

1.  Periplasmic transit and disulfide bond formation of the autotransported Shigella protein IcsA.

Authors:  L D Brandon; M B Goldberg
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

2.  Adaptive immune responses during Shigella dysenteriae type 1 infection: an in vitro stimulation with 57 kDa major antigenic OMP in the presence of anti-CD3 antibody.

Authors:  Ashim Kumar Bagchi; Ajoy Kumar Sinha; Rushita Adhikari; Joydeep Mukherjee
Journal:  Mol Cell Biochem       Date:  2009-11-14       Impact factor: 3.396

Review 3.  The pathogenesis of Shigella flexneri infection: lessons from in vitro and in vivo studies.

Authors:  D J Philpott; J D Edgeworth; P J Sansonetti
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-05-29       Impact factor: 6.237

4.  Complete DNA sequence and analysis of the large virulence plasmid of Shigella flexneri.

Authors:  M M Venkatesan; M B Goldberg; D J Rose; E J Grotbeck; V Burland; F R Blattner
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Antigen-specific CD8(+) T cells fail to respond to Shigella flexneri.

Authors:  Stephanie P Jehl; Amy M Doling; Kara S Giddings; Armelle Phalipon; Philippe J Sansonetti; Marcia B Goldberg; Michael N Starnbach
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

6.  Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T.

Authors:  J Wei; M B Goldberg; V Burland; M M Venkatesan; W Deng; G Fournier; G F Mayhew; G Plunkett; D J Rose; A Darling; B Mau; N T Perna; S M Payne; L J Runyen-Janecky; S Zhou; D C Schwartz; F R Blattner
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

7.  Immunoproteome analysis of soluble and membrane proteins of Shigella flexneri 2457T.

Authors:  Amy V Jennison; Rubhana Raqib; Naresh K Verma
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants.

Authors:  Ryan T Ranallo; Robert W Kaminski; Tonia George; Alexis A Kordis; Qing Chen; Kathleen Szabo; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

9.  Intradermal delivery of Shigella IpaB and IpaD type III secretion proteins: kinetics of cell recruitment and antigen uptake, mucosal and systemic immunity, and protection across serotypes.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Abhay U Andar; Cinthia B Drachenberg; Lillian van de Verg; Richard Walker; Wendy L Picking; Marcela F Pasetti
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

10.  Evaluation of immunogenicity and protective efficacy of orally delivered Shigella type III secretion system proteins IpaB and IpaD.

Authors:  Shannon J Heine; Jovita Diaz-McNair; Francisco J Martinez-Becerra; Shyamal P Choudhari; John D Clements; Wendy L Picking; Marcela F Pasetti
Journal:  Vaccine       Date:  2013-05-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.